Jesús San F Miguel (Jesús San Miguel, Jesús F San-Miguel, J F San Miguel, Jesus F San-Miguel, Jesús San Miguel, Jesus San Miguel, Jesús San-Miguel, Jesús F San Miguel, Jesus F San Miguel, Jesus San-Miguel, Jesus F F San-Miguel)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 93

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Blood cancer journal

Blood

Blood advances

UNIVERSITY OF NAVARRA

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UNIVERSITY OF NAVARRA Sep 01 2013

Spain

DIRECTOR OF CLINICAL AND TRANSLATIONAL MEDICINE :: CLINICA UNIVERSIDAD DE NAVARRA

UNIVERSITY OF SALAMANA

Spain

HEAD :: HEMATOLOGY DEPARTMENT

UNIVERSITY OF SALAMANCA

Spain

STAFF PHYSICIAN :: HEMATOLOGY

Hammersmith Hospital

United Kingdom

RESEARCH FELLOW AND HONORARY REGISTRAR :: ROYAL POSTGRADUATE MEDICAL SCHOOL

UNIVERSITY HOSPITAL OF SALAMANCA

Spain

RESIDENCY :: HEMATOLOGY

Publications

A Medina-Herrera, I Vazquez, I Cuenca, J M Rosa-Rosa, Beñat Ariceta, C Jimenez, M Fernandez-Mercado, M J Larrayoz, N C Gutierrez, M Fernandez-Guijarro, Verónica González De La Calle, Paula Rodriguez Otero, A Oriol, Laura Rosinol, A Alegre, F Escalante, Javier de la Rubia, A I Teruel, Felipe De Arriba, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, E M Ocio, N Puig, Juan José Lahuerta, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, null null
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood cancer journal 14 (1) (2024)
Irene M Ghobrial, Nicole J Gormley, Shaji K Kumar, Maria-Victoria Mateos-Manteca, Peter Leif Bergsagel, Marta Chesi, Madhav V Dhodapkar, Angela Dispenzieri, Rafael Fonseca, Gad A Getz, Efstathios Kastritis, Sigurður Yngvi Kristinsson, Jose-Angel Martinez-Climent, Salomon Manier, Catherine R Marinac, Francesco Maura, Gareth J Morgan, Faith E Davies, Omar Nadeem, Mario Nuvolone, Juan José Lahuerta, Elizabeth K O' Donnell, Felipe Prosper, Urvi A Shah, Romanos Sklavenitis-Pistofidis, Adam S Sperling, George S Vassiliou, Nikhil C Munshi, Philip E Castle, Kenneth C Anderson, Jesús San F Miguel
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma. Blood cancer discovery 5 (3) (2024)
Irene M Ghobrial, Nicole J Gormley, Shaji K Kumar, Maria-Victoria Mateos-Manteca, Peter Leif Bergsagel, Marta Chesi, Madhav V Dhodapkar, Angela Dispenzieri, Rafael Fonseca, Gad A Getz, Efstathios Kastritis, Sigurður Yngvi Kristinsson, Jose-Angel Martinez-Climent, Salomon Manier, Catherine R Marinac, Francesco Maura, Gareth J Morgan, Faith E Davies, Omar Nadeem, Mario Nuvolone, Juan José Lahuerta, Elizabeth K O' Donnell, Felipe Prosper, Urvi A Shah, Romanos Sklavenitis-Pistofidis, Adam S Sperling, George S Vassiliou, Nikhil C Munshi, Philip E Castle, Kenneth C Anderson, Jesús San F Miguel
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma. Blood cancer discovery 5 (3) (2024)
Irene M Ghobrial, Nicole J Gormley, Shaji K Kumar, Maria-Victoria Mateos-Manteca, Peter Leif Bergsagel, Marta Chesi, Madhav V Dhodapkar, Angela Dispenzieri, Rafael Fonseca, Gad A Getz, Efstathios Kastritis, Sigurður Yngvi Kristinsson, Jose-Angel Martinez-Climent, Salomon Manier, Catherine R Marinac, Francesco Maura, Gareth J Morgan, Faith E Davies, Omar Nadeem, Mario Nuvolone, Juan José Lahuerta, Elizabeth K O' Donnell, Felipe Prosper, Urvi A Shah, Romanos Sklavenitis-Pistofidis, Adam S Sperling, George S Vassiliou, Nikhil C Munshi, Philip E Castle, Kenneth C Anderson, Jesús San F Miguel
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma. Blood cancer discovery 5 (3) (2024)
Irene M Ghobrial, Nicole J Gormley, Shaji K Kumar, Maria-Victoria Mateos-Manteca, Peter Leif Bergsagel, Marta Chesi, Madhav V Dhodapkar, Angela Dispenzieri, Rafael Fonseca, Gad A Getz, Efstathios Kastritis, Sigurður Yngvi Kristinsson, Jose-Angel Martinez-Climent, Salomon Manier, Catherine R Marinac, Francesco Maura, Gareth J Morgan, Faith E Davies, Omar Nadeem, Mario Nuvolone, Juan José Lahuerta, Elizabeth K O' Donnell, Felipe Prosper, Urvi A Shah, Romanos Sklavenitis-Pistofidis, Adam S Sperling, George S Vassiliou, Nikhil C Munshi, Philip E Castle, Kenneth C Anderson, Jesús San F Miguel
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma. Blood cancer discovery 5 (3) (2024)
Noemi Puig, Cristina Agullo Roca, Teresa Contreras Sanfeliciano, María-Teresa Cedena, Joaquín Martínez-López, Albert Ortiol, María-Jesús Blanchard, Rafael Rios-Tamayo, Belén Iñigo Rodríguez, Anna Sureda, Sunil Lakhwani, Javier de la Rubia Comos, Verónica González De La Calle, Valentín Cabañas, Luis Palomera, José María M Moraleda, Joan Bargay, Sergio Castro, Laura Rosinol, Joan Bladé, Jesús San F Miguel, Juan-José Lahuerta, Juan José Lahuerta, Maria-Victoria Mateos-Manteca
Measurable Residual Disease by Mass Spectrometry and Next-Generation Flow to Assess Treatment Response in Myeloma. Blood (2024)
Esperanza Martin-Sanchez, Luis Esteban Tamariz-Amador, Camilla Guerrero, Anastasiia Zherniakova, Aintzane Zabaleta, Catarina Maia, Laura Blanco, Diego Alignani, Maria-Antonia Fortuño, Carlos Grande, Andrea Manubens, Jose-Maria Arguiñano, Clara Gomez, Ernesto Perez-Persona, Iñigo Olazabal, Itziar Oiartzabal, Carlos Panizo, Felipe Prosper, Jesús San F Miguel, Paula Rodriguez Otero, Juan José Lahuerta, null null
Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19. Blood cancer journal 14 (1) (2024)
A Medina-Herrera, I Vazquez, I Cuenca, J M Rosa-Rosa, Beñat Ariceta, C Jimenez, M Fernandez-Mercado, M J Larrayoz, N C Gutierrez, M Fernandez-Guijarro, Verónica González De La Calle, Paula Rodriguez Otero, A Oriol, Laura Rosinol, A Alegre, F Escalante, Javier de la Rubia, A I Teruel, Felipe De Arriba, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, E M Ocio, N Puig, Juan José Lahuerta, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, null null
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood cancer journal 14 (1) (2024)
Esperanza Martin-Sanchez, Laura Blanco-Fernández, Peter S Kim, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Tomas Jelinek, Catia Simoes, Felipe Prosper, Jesús San F Miguel, Ana Alfonso, Juan-Miguel Bergua, Rebeca Rodriguez-Veiga, Susana Vives, David Martínez-Cuadrón, Pau Montesinos, Juan José Lahuerta, Aintzane Zabaleta
Targeting CD38 by isatuximab and a CD38/CD3xCD28 trispecific T-cell engager in old patients with acute myeloid leukemia. Blood advances (2024)
Maria Luisa Palacios-Berraquero, Paula Rodriguez-Marquez, Maria Eréndira Calleja-Cervantes, Nerea Berastegui, Aintzane Zabaleta, Leire Burgos, Diego Alignani, Patxi San Martin-Uriz, Amaia Vilas-Zornoza, Saray Rodriguez-Diaz, Susana I Inoges, Ascensión López-Diaz-de-Cerio, Sofia Huerga, Luis Esteban Tamariz-Amador, Jose J Rifon, Ana Alfonso, Juan Jose Lasarte, Juan José Lahuerta, Mikel Hernaez, Paula Rodriguez Otero, Jesús San F Miguel, Teresa Ezponda, Juan Roberto Rodriguez-Madoz, Felipe Prosper
Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in Multiple Myeloma. Blood advances (2024)
Esperanza Martin-Sanchez, Laura Blanco-Fernández, Peter S Kim, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Tomas Jelinek, Catia Simoes, Felipe Prosper, Jesús San F Miguel, Ana Alfonso, Juan-Miguel Bergua, Rebeca Rodriguez-Veiga, Susana Vives, David Martínez-Cuadrón, Pau Montesinos, Juan José Lahuerta, Aintzane Zabaleta
Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia. Blood advances 8 (15) (2024)
Esperanza Martin-Sanchez, Laura Blanco-Fernández, Peter S Kim, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Tomas Jelinek, Catia Simoes, Felipe Prosper, Jesús San F Miguel, Ana Alfonso, Juan-Miguel Bergua, Rebeca Rodriguez-Veiga, Susana Vives, David Martínez-Cuadrón, Pau Montesinos, Juan José Lahuerta, Aintzane Zabaleta
Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia. Blood advances 8 (15) (2024)
Irene M Ghobrial, Nicole J Gormley, Shaji K Kumar, Maria-Victoria Mateos-Manteca, Peter Leif Bergsagel, Marta Chesi, Madhav V Dhodapkar, Angela Dispenzieri, Rafael Fonseca, Gad A Getz, Efstathios Kastritis, Sigurður Yngvi Kristinsson, Jose-Angel Martinez-Climent, Salomon Manier, Catherine R Marinac, Francesco Maura, Gareth J Morgan, Faith E Davies, Omar Nadeem, Mario Nuvolone, Juan José Lahuerta, Elizabeth K O' Donnell, Felipe Prosper, Urvi A Shah, Romanos Sklavenitis-Pistofidis, Adam S Sperling, George S Vassiliou, Nikhil C Munshi, Philip E Castle, Kenneth C Anderson, Jesús San F Miguel
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma. Blood cancer discovery 5 (3) (2024)
Esperanza Martin-Sanchez, Luis Esteban Tamariz-Amador, Camilla Guerrero, Anastasiia Zherniakova, Aintzane Zabaleta, Catarina Maia, Laura Blanco, Diego Alignani, Maria-Antonia Fortuño, Carlos Grande, Andrea Manubens, Jose-Maria Arguiñano, Clara Gomez, Ernesto Perez-Persona, Iñigo Olazabal, Itziar Oiartzabal, Carlos Panizo, Felipe Prosper, Jesús San F Miguel, Paula Rodriguez Otero, Juan José Lahuerta, null null
Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19. Blood cancer journal 14 (1) (2024)
Irene M Ghobrial, Nicole J Gormley, Shaji K Kumar, Maria-Victoria Mateos-Manteca, Peter Leif Bergsagel, Marta Chesi, Madhav V Dhodapkar, Angela Dispenzieri, Rafael Fonseca, Gad A Getz, Efstathios Kastritis, Sigurður Yngvi Kristinsson, Jose-Angel Martinez-Climent, Salomon Manier, Catherine R Marinac, Francesco Maura, Gareth J Morgan, Faith E Davies, Omar Nadeem, Mario Nuvolone, Juan José Lahuerta, Elizabeth K O' Donnell, Felipe Prosper, Urvi A Shah, Romanos Sklavenitis-Pistofidis, Adam S Sperling, George S Vassiliou, Nikhil C Munshi, Philip E Castle, Kenneth C Anderson, Jesús San F Miguel
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma. Blood cancer discovery 5 (3) (2024)
Irene M Ghobrial, Nicole J Gormley, Shaji K Kumar, Maria-Victoria Mateos-Manteca, Peter Leif Bergsagel, Marta Chesi, Madhav V Dhodapkar, Angela Dispenzieri, Rafael Fonseca, Gad A Getz, Efstathios Kastritis, Sigurður Yngvi Kristinsson, Jose-Angel Martinez-Climent, Salomon Manier, Catherine R Marinac, Francesco Maura, Gareth J Morgan, Faith E Davies, Omar Nadeem, Mario Nuvolone, Juan José Lahuerta, Elizabeth K O' Donnell, Felipe Prosper, Urvi A Shah, Romanos Sklavenitis-Pistofidis, Adam S Sperling, George S Vassiliou, Nikhil C Munshi, Philip E Castle, Kenneth C Anderson, Jesús San F Miguel
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma. Blood cancer discovery 5 (3) (2024)
Irene M Ghobrial, Nicole J Gormley, Shaji K Kumar, Maria-Victoria Mateos-Manteca, Peter Leif Bergsagel, Marta Chesi, Madhav V Dhodapkar, Angela Dispenzieri, Rafael Fonseca, Gad A Getz, Efstathios Kastritis, Sigurður Yngvi Kristinsson, Jose-Angel Martinez-Climent, Salomon Manier, Catherine R Marinac, Francesco Maura, Gareth J Morgan, Faith E Davies, Omar Nadeem, Mario Nuvolone, Juan José Lahuerta, Elizabeth K O' Donnell, Felipe Prosper, Urvi A Shah, Romanos Sklavenitis-Pistofidis, Adam S Sperling, George S Vassiliou, Nikhil C Munshi, Philip E Castle, Kenneth C Anderson, Jesús San F Miguel
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma. Blood cancer discovery (2024)
Aintzane Zabaleta, Laura Blanco, Peter S Kim, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Marta Lasa, Luis Esteban Tamariz-Amador, Paula Rodriguez Otero, Jesús San F Miguel, Bruno Paiva, Esperanza Martin-Sanchez
A CD38/CD3xCD28 trispecific T-cell engager as a potentially active agent in multiple myeloma patients relapsed and/or refractory to anti-CD38 monoclonal antibodies. British journal of haematology (2024)
A Medina-Herrera, I Vazquez, I Cuenca, J M Rosa-Rosa, Beñat Ariceta, C Jimenez, M Fernandez-Mercado, M J Larrayoz, N C Gutierrez, M Fernandez-Guijarro, Verónica González De La Calle, Paula Rodriguez Otero, A Oriol, Laura Rosinol, A Alegre, F Escalante, Javier de la Rubia, A I Teruel, Felipe De Arriba, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, E M Ocio, N Puig, Juan José Lahuerta, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, null null
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood cancer journal 14 (1) (2024)
Esperanza Martin-Sanchez, Laura Blanco-Fernández, Peter S Kim, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Tomas Jelinek, Catia Simoes, Felipe Prosper, Jesús San F Miguel, Ana Alfonso, Juan-Miguel Bergua, Rebeca Rodriguez-Veiga, Susana Vives, David Martínez-Cuadrón, Pau Montesinos, Juan José Lahuerta, Aintzane Zabaleta
Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia. Blood advances 8 (15) (2024)
Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Paula Rodriguez Otero, Verónica González-Calle, Marta Sonia Gonzalez, Albert Ortiol, Norma C Gutiérrez, Rafael Rios-Tamayo, Laura Rosinol, Miguel Angel Alvarez Rivas, Joan Bargay, Ana Pilar Gonzalez-Rodriguez, Adrian Alegre, Fernando Escalante, María Belén Iñigo Rodríguez, Javier de la Rubia, Ana Isabel Teruel, Felipe De Arriba, Luis Palomera, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, Marta Reinoso-Segura, Aránzazu García Mateo, Enrique María Ocio, Juan José Lahuerta, Noemi Puig, María-Teresa Cedena, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, null null
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Paula Rodriguez Otero, Verónica González-Calle, Marta Sonia Gonzalez, Albert Ortiol, Norma C Gutiérrez, Rafael Rios-Tamayo, Laura Rosinol, Miguel Angel Alvarez Rivas, Joan Bargay, Ana Pilar Gonzalez-Rodriguez, Adrian Alegre, Fernando Escalante, María Belén Iñigo Rodríguez, Javier de la Rubia, Ana Isabel Teruel, Felipe De Arriba, Luis Palomera, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, Marta Reinoso-Segura, Aránzazu García Mateo, Enrique María Ocio, Juan José Lahuerta, Noemi Puig, María-Teresa Cedena, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, null null
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Esperanza Martin-Sanchez, Luis Esteban Tamariz-Amador, Camilla Guerrero, Anastasiia Zherniakova, Aintzane Zabaleta, Catarina Maia, Laura Blanco, Diego Alignani, Maria-Antonia Fortuño, Carlos Grande, Andrea Manubens, Jose-Maria Arguiñano, Clara Gomez, Ernesto Perez-Persona, Iñigo Olazabal, Itziar Oiartzabal, Carlos Panizo, Felipe Prosper, Jesús San F Miguel, Paula Rodriguez Otero, Juan José Lahuerta, null null
Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19. Blood cancer journal 14 (1) (2024)
Meletios- Athanasios Dimopoulos, Jesús San F Miguel
Reply to S. Al Hadidi et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (9) (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Meletios- Athanasios Dimopoulos, Jesús San F Miguel
Reply to S. Al Hadidi et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, Amaia Etxebeste, Maddalen Jimenez, Cristina Perez, Raquel Ordoñez, César Cobaleda, Cirino Botta, Vicente Jose Fresquet, Sergio Roa, Ibai Goicoechea, Catarina Maia, Miren Lasaga, Marta Chesi, Peter Leif Bergsagel, Maria J Larrayoz, María-José Calasanz, Elena Campos-Sanchez, Jorge Martinez-Cano, Carlos Panizo, Paula Rodriguez-Otero, Silvestre Vincent, Giovanna Roncador, Patricia Gonzalez, Satoru Takahashi, Samuel G Katz, Loren D Walensky, Shannon M Ruppert, Elisabeth A Lasater, Maria Amann, Teresa Lozano, Diana Llopiz, Pablo Sarobe, Juan Jose Lasarte, Nuria Planell, David Gomez-Cabrero, Olga Mikhaylovna Plotnikova, Anna Kurilovich, Maria Victoria Revuelta, Leandro Cerchietti, Xabier Agirre, Jesús San F Miguel, Juan José Lahuerta, Felipe Prosper, Jose-Angel Martinez-Climent
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nature medicine 29 (3) (2023)
Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, Amaia Etxebeste, Maddalen Jimenez, Cristina Perez, Raquel Ordoñez, César Cobaleda, Cirino Botta, Vicente Jose Fresquet, Sergio Roa, Ibai Goicoechea, Catarina Maia, Miren Lasaga, Marta Chesi, Peter Leif Bergsagel, Maria J Larrayoz, María-José Calasanz, Elena Campos-Sanchez, Jorge Martinez-Cano, Carlos Panizo, Paula Rodriguez-Otero, Silvestre Vincent, Giovanna Roncador, Patricia Gonzalez, Satoru Takahashi, Samuel G Katz, Loren D Walensky, Shannon M Ruppert, Elisabeth A Lasater, Maria Amann, Teresa Lozano, Diana Llopiz, Pablo Sarobe, Juan Jose Lasarte, Nuria Planell, David Gomez-Cabrero, Olga Mikhaylovna Plotnikova, Anna Kurilovich, Maria Victoria Revuelta, Leandro Cerchietti, Xabier Agirre, Jesús San F Miguel, Juan José Lahuerta, Felipe Prosper, Jose-Angel Martinez-Climent
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nature medicine (2023)
Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, Amaia Etxebeste, Maddalen Jimenez, Cristina Perez, Raquel Ordoñez, César Cobaleda, Cirino Botta, Vicente Jose Fresquet, Sergio Roa, Ibai Goicoechea, Catarina Maia, Miren Lasaga, Marta Chesi, Peter Leif Bergsagel, Maria J Larrayoz, María-José Calasanz, Elena Campos-Sanchez, Jorge Martinez-Cano, Carlos Panizo, Paula Rodriguez-Otero, Silvestre Vincent, Giovanna Roncador, Patricia Gonzalez, Satoru Takahashi, Samuel G Katz, Loren D Walensky, Shannon M Ruppert, Elisabeth A Lasater, Maria Amann, Teresa Lozano, Diana Llopiz, Pablo Sarobe, Juan Jose Lasarte, Nuria Planell, David Gomez-Cabrero, Olga Mikhaylovna Plotnikova, Anna Kurilovich, Maria Victoria Revuelta, Leandro Cerchietti, Xabier Agirre, Jesús San F Miguel, Juan José Lahuerta, Felipe Prosper, Jose-Angel Martinez-Climent
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nature medicine 29 (3) (2023)
Cirino Botta, Cristina Perez, Marta Larrayoz, Noemi Puig, María-Teresa Cedena, Rosalinda Termini, Ibai Goicoechea, Sara Rodriguez, Aintzane Zabaleta, Aitziber Lopez, Sarai Sarvide, Laura Blanco, Daniele M Papetti, Marco Salvatore Nobile, Daniela Besozzi, Massimo Gentile, Pierpaolo Correale, Sergio Siragusa, Albert Oriol, Maria Esther González-Garcia, Anna Sureda, Felipe de Arriba, Rafael Rios-Tamayo, José María M Moraleda, Mercedes Gironella, Miguel T Hernandez, Joan Bargay, Luis Palomera, Albert Pérez-Montaña, Hartmut Goldschmidt, Hervé Avet-Loiseau, Aldo M Roccaro, Alberto Orfao, Joaquin Martinez-Lopez, Laura Rosinol, Juan-José Lahuerta, Joan Bladé, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Jose-Angel Martinez-Climent, Juan José Lahuerta, null null, null null
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance. Nature communications 14 (1) (2023)
Catia Simoes, Sara Villar, Beñat Ariceta, Juan-José Garcés, Leire Burgos, Diego Alignani, Sarai Sarvide, David Martínez-Cuadrón, Juan-Miguel Bergua, Susana Vives, Lorenzo Algarra, Mar Tormo, Pilar Martinez, Josefina Serrano, Pilar Herrera, Fernando Ramos, Olga Salamero, Esperanza Lavilla, Cristina Gil, Jose-Luis Lopez-Lorenzo, Maria-Belen Vidriales, Carmen Chillon, Jorge Labrador, Jose-Francisco Falantes, María-José Sayas, Rosa María Ayala, Joaquin Martinez Lopez, Ana Alfonso Pierola, María-José Calasanz, Felipe Prosper, Jesús San F Miguel, Miguel Á Sanz, Juan José Lahuerta, Pau Montesinos, null null
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia. British journal of haematology (2023)
Laura Rosinol, Albert Ortiol, Rafael Rios-Tamayo, María-Jesús Blanchard, Isidro Jarque, Joan Bargay, Miguel-Teodoro T Hernandez Garcia, Valentín Cabañas, Estrella Carrillo-Cruz, Anna Sureda, Joaquin Martinez Lopez, Isabel Krsnik, Maria-Esther Gonzalez, Luis Felipe Casado Montero, Josep-Maria Marti, Cristina Encinas, Felipe de Arriba, Luis Palomera, Maria Antonia Sampol, Yolanda Gonzalez-Montes, Elena Cabezudo, Juan José Lahuerta, Noemi Puig, Maria-Teresa Cedena, Javier de la Cruz, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Juan-José Lahuerta, Joan Bladé
LENALIDOMIDE AND DEXAMETHASONE WITH OR WITHOUT IXAZOMIB MAINTENANCE TAILORED BY RESIDUAL DISEASE STATUS IN MYELOMA. Blood (2023)
Meletios- Athanasios Dimopoulos, Jesús San F Miguel
Reply to S. Al Hadidi et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (9) (2023)
Juan José Lahuerta, Irene Manrique, Julie A Rytlewski, Timothy Campbell, Christian C Kazanecki, Nathan Martin, Larry D Anderson, Jesus G Berdeja, Sagar Lonial, Noopur S Raje, Yi Lin, Phillipe Moreau, Jesús San F Miguel, Nikhil C Munshi, Shari Kaiser
Time-dependent prognostic value of serological and measurable residual disease assessments after idecabtagene vicleucel. Blood cancer discovery (2023)
Juan José Lahuerta, Anastasiia Zherniakova, Jorge M Nuñez-Córdoba, Paula Rodriguez Otero, Qian Shi, Nikhil C Munshi, Brian Durie, Jesús San F Miguel
Impact of treatment effect on MRD and PFS: an aggregate analysis from randomized clinical trials in multiple myeloma. Blood advances (2023)
Juan José Lahuerta, Jesús San F Miguel
Myeloma evades T cell-engaging therapies. Nature cancer 4 (11) (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Curly T C M Morris, Francesca Gay, Niels W C J van de Donk, Ioannis Ntanasis-Stathopoulos, Annette Juul Vangsted, Christoph Driessen, Schjesvold Fredrik, Claudio Cerchione, Sonja Zweegman, Roman Hájek, Phillipe Moreau, Hermann Einsele, Jesús San F Miguel, Mario Boccadoro, Meletios- Athanasios Dimopoulos, Pieter Sonneveld, Heinz Ludwig
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN). Leukemia (2023)
Enrique María Ocio, Aurore Perrot, Pierre Bories, Jesús San F Miguel, Igor W Blau, Lionel Karlin, Joaquin Martinez-Lopez, Song-Yau Wang, Sara Bringhen, Magda Marcatti, Maria-Victoria Mateos-Manteca, Paula Rodriguez Otero, Stefania Oliva, Axel Nogai, Nadia Le Roux, Liyan Dong, Sandrine Macé, Matthieu Gassiot, Thomas Fitzmaurice, Corina Oprea, Phillipe Moreau
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation. Leukemia (2023)
Camilla Guerrero, Noemi Puig, María-Teresa Cedena, María-José Calasanz, Norma C Gutiérrez, Manuela Fernandez, Albert Ortiol, Rafael Rios-Tamayo, Miguel-Teodoro T Hernandez Garcia, Rafael Martínez-Martínez, Joan Bargay, Felipe de Arriba, Luis Palomera, Ana Pilar Gonzalez-Rodriguez, Marta-Sonia Gonzalez Perez, Alberto Orfao, Maria-Victoria Mateos-Manteca, Joaquin Martinez-Lopez, Laura Rosinol, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, Juan José Lahuerta
Predictors of unsustained measurable residual disease negativity in transplant-eligible multiple myeloma patients. Blood (2023)
Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, Amaia Etxebeste, Maddalen Jimenez, Cristina Perez, Raquel Ordoñez, César Cobaleda, Cirino Botta, Vicente Jose Fresquet, Sergio Roa, Ibai Goicoechea, Catarina Maia, Miren Lasaga, Marta Chesi, Peter Leif Bergsagel, Maria J Larrayoz, María-José Calasanz, Elena Campos-Sanchez, Jorge Martinez-Cano, Carlos Panizo, Paula Rodriguez-Otero, Silvestre Vincent, Giovanna Roncador, Patricia Gonzalez, Satoru Takahashi, Samuel G Katz, Loren D Walensky, Shannon M Ruppert, Elisabeth A Lasater, Maria Amann, Teresa Lozano, Diana Llopiz, Pablo Sarobe, Juan Jose Lasarte, Nuria Planell, David Gomez-Cabrero, Olga Mikhaylovna Plotnikova, Anna Kurilovich, Maria Victoria Revuelta, Leandro Cerchietti, Xabier Agirre, Jesús San F Miguel, Juan José Lahuerta, Felipe Prosper, Jose-Angel Martinez-Climent
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nature medicine 29 (3) (2023)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Curly T C M Morris, Francesca Gay, Niels W C J van de Donk, Ioannis Ntanasis-Stathopoulos, Annette Juul Vangsted, Christoph Driessen, Schjesvold Fredrik, Claudio Cerchione, Sonja Zweegman, Roman Hájek, Phillipe Moreau, Hermann Einsele, Jesús San F Miguel, Mario Boccadoro, Meletios- Athanasios Dimopoulos, Pieter Sonneveld, Heinz Ludwig
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN). Leukemia (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Leire Burgos, Luis Esteban Tamariz-Amador, Noemi Puig, María-Teresa Cedena, Camilla Guerrero, Tomas Jelinek, Sarah Johnson, Paolo Milani, Lourdes Cordon, Jose J Perez, Marta Lasa, Rosalinda Termini, Albert Ortiol, Miguel-Teodoro T Hernandez Garcia, Luis Palomera, Rafael Martinez-Martinez, Javier de la Rubia, Felipe de Arriba, Rafael Rios-Tamayo, Maria-Esther Gonzalez, Mercedes Gironella, Valentín Cabañas, Maria Casanova, Isabel Krsnik, Albert Perez-Montaña, Verónica González De La Calle, Paula Rodriguez Otero, Vladimir Maisnar, Roman Hájek, Frits Van Rhee, Victor Jimenez-Zepeda, Giovanni Palladini, Giampaolo Merlini, Alberto Orfao, Javier de la Cruz, Joaquin Martinez Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Juan José Lahuerta, null null
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Noemí Puig, María-Teresa Contreras, Cristina Agulló, Joaquin Martinez Lopez, Albert Ortiol, María-Jesús Blanchard, Rafael Rios-Tamayo, Jesús Martín, María-Belén Iñigo, Anna Sureda, Miguel-Teodoro T Hernandez Garcia, Javier de la Rubia, Verónica González De La Calle, Isabel Krsnik, Valentín Cabañas, Luis Palomera, José María M Moraleda, Joan Bargay, María-Teresa Cedena, Juan José Lahuerta, Laura Rosiñol, Joan Bladé, Jesús San F Miguel, Juan-José Lahuerta, Maria-Victoria Mateos-Manteca
Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma. Blood advances 6 (11) (2022)
Juan-José Garcés, María-Teresa Cedena, Noemi Puig, Leire Burgos, Jose J Perez, Lourdes Cordon, Juan A Flores-Montero, Luzalba Sanoja-Flores, María-José Calasanz, Albert Ortiol, María-Jesús Blanchard, Rafael Rios-Tamayo, Jesús Martín-Sánchez, Rafael Martínez-Martinez, Joan Bargay, Anna Sureda, Javier de la Rubia, Miguel-Teodoro T Hernandez Garcia, Paula Rodriguez Otero, Javier de la Cruz, Alberto Orfao, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Jesús San F Miguel, Juan José Lahuerta
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Maria-Victoria Mateos-Manteca, Katja C Weisel, Valerio De Stefano, Hartmut Goldschmidt, Michel Delforge, Mohamad Mohty, Michele Cavo, Ravi Vij, Joanne Lindsey-Hill, Dominik Dytfeld, Emanuele Angelucci, Aurore Perrot, Reuben Benjamin, Niels W C J van de Donk, Enrique M Ocio, Christof Scheid, Francesca Gay, Wilfried Roeloffzen, Paula Rodriguez-Otero, Annemiek Broijl, Anna Potamianou, Caline Sakabedoyan, Maria Semerjian, Sofia Keim, Vadim Strulev, Jordan M Schecter, Martin Vogel, Robert Wapenaar, Tonia Nesheiwat, Jesús San F Miguel, Pieter Sonneveld, Hermann Einsele, Philippe Moreau
LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma. Leukemia 36 (5) (2022)
Laurence L de Leval, Ash A Alizadeh, Peter Leif Bergsagel, Elias Campo, Andrew John Davies, Ahmet Dogan, Jude Fitzgibbon, Steven M Horwitz, Ari M Melnick, William George Morice, Ryan D Morin, Bertrand Nadel, Stefano A Pileri, Richard Rosenquist, Davide Rossi, Itziar Salaverria, Christian Steidl, Steven P Treon, Andrew D Zelenetz, Ranjana H Advani, Carl E Allen, Stephen M Ansell, Wing C John Chan, James R Cook, Lucy B M Cook, Francesco d'Amore, Stefan Dirnhofer, Martin Dreyling, Kieron Dunleavy, Andrew L Feldman, Falko Fend, Philippe Gaulard, Paolo Ghia, John G Gribben, Olivier Hermine, Daniel James Hodson, Eric D Hsi, Giorgio Ga Inghirami, Elaine S Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfram Klapper, Won Seog Kim, Rebecca L King, Young-Hyeh Ko, Ann Steward LaCasce, Georg Lenz, José I Martin-Subero, Miguel Angel Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla-Fend, Scott J Rodig, Andreas Rosenwald, Gilles Andre Salles, Jesús San F Miguel, Kerry Joane Savage, Laurie Helen Sehn, Gianpietro C Semenzato, Louis M Staudt, Steven Howard Swerdlow, Constantine S Tam, Judith Trotman, Julie M Vose, Oliver Weigert, Wyndham H Wilson, Jane N Winter, Catherine J Wu, Pier Luigi Luigi Zinzani, Emanuele Zucca, Adam Bagg, David W Scott
Genomic profiling for clinical decision making in lymphoid neoplasms. Blood 140 (21) (2022)
Faith E Davies, Charlotte Pawlyn, Saad Z Usmani, Jesús San F Miguel, Hermann Einsele, Eileen Mary Boyle, Jill Corre, Daniel Auclair, Hearn Jay Cho, Sagar Lonial, Pieter Sonneveld, A Keith Stewart, Peter Leif Bergsagel, Martin F Kaiser, Katja Weisel, Jonathan J Keats, Joseph R Mikhael, Kathryn E Morgan, Irene M Ghobrial, Robert Z Orlowski, Carl Ola Landgren, Francesca Gay, Joseph Caers, Wee-Joo Chng, Ajai Chari, Brian A Walker, Shaji K Kumar, Luciano José Megale Costa, Kenneth C Anderson, Gareth J Morgan
Perspectives on the Risk-Stratified Treatment of Multiple Myeloma. Blood cancer discovery 3 (4) (2022)
Adrián Mosquera Orgueira, Marta Sonia González Pérez, Jose Diaz Arias, Laura Rosinol, Albert Ortiol, Ana Isabel Teruel, Joaquin Martinez Lopez, Luis Palomera, Miquel Granell, Maria Jesus Blanchard, Javier de la Rubia, Ana López de la Guia, Rafael Rios-Tamayo, Anna Sureda, Miguel-Teodoro T Hernandez Garcia, Enrique Bengoechea, María José Calasanz, Norma Gutierrez, Maria Luis Martin, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, null null
Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group. Blood cancer journal 12 (4) (2022)
Catia Simoes, Maria Carmen Chillon, David Martínez-Cuadrón, María-José Calasanz, María-Belén Vidriales, Iria Vazquez, Montserrat Hernández-Ruano, Beñat Ariceta, Paula Aguirre-Ruiz, Leire Burgos, Diego Alignani, Sarai Sarvide, Sara Villar, Ana Alfonso, Felipe Prosper, Rosa María Ayala, Joaquin Martínez-López, Juan-Miguel Bergua, Susana Vives, Jose Antonio Perez-Simon, María García-Fortes, Teresa Bernal Del Castillo, Mercedes Colorado, Mayte Olave, Juan I Rodríguez-Gutiérrez, Jorge Labrador, Marcos González-Díaz, Jesús San F Miguel, Miguel A Sanz, Pau Montesinos, Juan José Lahuerta
Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia. Blood advances (2022)
Michel Delforge, Nina Shah, Jesús San F Miguel, Julia Braverman, Devender S Dhanda, Ling Shi, Shien Guo, Peiwen Yu, Weiqin Liao, Timothy B Campbell, Nikhil C Munshi
Health-related quality of life with idecabtagene vicleucel in relapsed and refractory multiple myeloma. Blood advances 6 (4) (2022)
Meletios- Athanasios Dimopoulos, Dominik Dytfeld, Sebastian Grosicki, Phillipe Moreau, Naoki Takezako, Mitsuo Hori, Xavier Leleu, Richard LeBlanc, Kenshi Suzuki, Marc-Steffen Raab, Paul Gerard Richardson, Mihaela Popa McKiver, Ying-Ming Jou, David Yao, Prianka Das, Jesús San F Miguel
Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Final Overall Survival Analysis From the Randomized Phase II ELOQUENT-3 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Rosalinda Termini, David Zihala, Evangelos Terpos, Albert Perez-Montaña, Tomas Jelinek, Marc-Steffen Raab, Niels Weinhold, Elias Karl Mai, Anna Luise Grab, Jill Corre, François Vergez, Antonio Sacco, Marco Chiarini, Viviana Giustini, Alessandra Tucci, Sara Rodriguez, Cristina Moreno, Cristina Perez, Catarina Maia, Esperanza Martin-Sanchez, Camilla Guerrero, Cirino Botta, Juan-José Garcés, Aitziber Lopez, Luis Esteban Tamariz-Amador, Felipe Prosper, Joan Bargay, Maria-Elena Cabezudo, Enrique María Ocio, Roman Hájek, Joaquin Martinez Lopez, Fernando Solano, Rebeca Iglesias, Artur Paiva, Catarina Geraldes, Helena Vitoria, Clara Gomez, Felipe De Arriba, Heinz Ludwig, Antoni Garcia-Guiñon, María Casanova, Adrian Alegre, Valentín Cabañas, Maialen Sirvent, Albert Ortiol, Javier de la Rubia, Jose-Ángel Hernández-Rivas, Luis Palomera, Maria Sarasa, Pablo Rios, Noemi Puig, Maria-Victoria Mateos-Manteca, Juan A Flores-Montero, Alberto Orfao, Hartmut Goldschmidt, Herve Avet-Loiseau, Aldo M Roccaro, Jesús San F Miguel, Juan José Lahuerta, null null
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Juan José Lahuerta, Jesús San F Miguel, Herve Avet-Loiseau
MRD in multiple myeloma: does CR really matter? Blood (2022)
Elias Campo, Elaine S Jaffe, James R Cook, Leticia Quintanilla-Fend, Steven H Swerdlow, Kenneth C Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, Stefan Dirnhofer, Ahmet Dogan, Andrew L Feldman, Falko Fend, Jonathan W Friedberg, Philippe Gaulard, Paolo Ghia, Steven M Horwitz, Rebecca L King, Gilles Andre Salles, Jesús San F Miguel, John Francis Seymour, Steven P Treon, Julie M Vose, Emanuele Zucca, Ranjana Advani, Stephen Ansell, Wing-Yan Au, Carlos Barrionuevo, Peter Leif Bergsagel, Wing C Chan, Jeffrey I Cohen, Francesco d'Amore, Andrew John Davies, Brunangelo Falini, Irene M Ghobrial, Mariusz A Wasik, John G Gribben, Eric D Hsi, Brad S Kahl, Won-Seog Kim, Shaji K Kumar, Ann Steward LaCasce, Camille Laurent, Georg Lenz, John P Leonard, Michael P Link, Armando Lopez-Guillermo, Maria-Victoria Mateos-Manteca, Elizabeth A Macintyre, Ari M Melnick, Judith Trotman, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano A Pileri, Miguel Angel Piris, Barbara Pro, Vincent Rajkumar, Steven T Rosen, Birgitta Sander, Laurie Sehn, Margaret A Shipp, Sonali M Smith, Louis M Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H Wilson, Tadashi Yoshino, Pier Luigi Luigi Zinzani, Martin Dreyling, David W Scott, Jane N Winter, Andrew D Zelenetz
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood 140 (11) (2022)
Adam David Cohen, Maria-Victoria Mateos-Manteca, Yael C Cohen, Paula Rodriguez Otero, Juan José Lahuerta, Niels W C J van de Donk, Thomas G Martin, Attaya Suvannasankha, Kevin C De Braganca, Christina Corsale, Jordan M Schecter, Helen Varsos, William Deraedt, Liwei Wang, Martin Vogel, Tito Roccia, Xiaoying Xu, Pankaj Mistry, Enrique Zudaire, Muhammad Akram, Tonia Nesheiwat, Lida Pacaud, Irit Avivi, Jesús San F Miguel
Efficacy and safety of cilta-cel in patients with progressive MM after exposure to other BCMA-targeting agents. Blood (2022)
Sara Rodriguez, Jon Celay, Ibai Goicoechea, Cristina Jiménez, Cirino Botta, Maria-José Garcia-Barchino, Juan-José Garcés, Marta Larrayoz, Susana Santos, Diego Alignani, Amaia Vilas-Zornoza, Cristina Perez, Sonia Garate, Sarai Sarvide, Aitziber Lopez, Hans-Christian Reinhardt, Yolanda R Carrasco, Isidro Sanchez-Garcia, Maria-Jose Larrayoz, María-José Calasanz, Carlos Panizo, Felipe Prosper, José María Lamo-Espinosa, Marina Motta, Alessandra Tucci, Antonio Sacco, Massimo Gentile, Sara Duarte, Helena Vitoria, Catarina Geraldes, Artur Paiva, Noemi Puig, Miriam Santero, Aldo M Roccaro, Gema Fuerte, Jesús San F Miguel, Jose-Angel Martinez-Climent, Juan José Lahuerta
Preneoplastic somatic mutations including MYD88 L265P in lymphoplasmacytic lymphoma. Science advances 8 (3) (2022)
Juan-José Garcés, Jesús San F Miguel, Juan José Lahuerta
Reply to I.V. Kostopoulos et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Paula Rodriguez-Marquez, Maria Eréndira Calleja-Cervantes, Guillermo Serrano, Marta Garrote, Maria L Palacios-Berraquero, Angel Martin-Mallo, Cristina Calviño-Sampedro, Marta Español-Rego, Candela Ceballos, Teresa Lozano, Patxi San Martin-Uriz, Amaia Vilas-Zornoza, Saray Rodriguez-Diaz, Rebeca Martinez-Turrillas, Patricia Jauregui, Diego Alignani, María Cruz Viguria, Margarita Redondo, Mariona Pascal, Beatriz Martin-Antonio, Manel Juan, Alvaro Urbano-Ispizua, Paula Rodriguez Otero, Ana Alfonso, Juan José Lahuerta, Juan Jose Lasarte, Susana Inoges, Ascensión López-Díaz de Cerio, Jesús San F Miguel, Carlos Fernández de Larrea, Mikel Hernaez, Juan Roberto Rodriguez-Madoz, Felipe Prosper
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome. Science advances 8 (39) (2022)
Tomas Jelinek, Renata Bezděková, David Zihala, Tereza Ševčíková, Anjana Anilkumar Sithara, Lenka Pospisilova, Sabina Sevcikova, Petra Polackova, Martin Stork, Zdenka Knechtova, Ondrej Venglar, Veronika Kapustová, Tereza Popkova, Ludmila Muronova, Zuzana Chyra, Matous Hrdinka, Michal Simicek, Juan-José Garcés, Noemi Puig, María-Teresa Cedena, Artur Jurczyszyn, Jorge J Castillo, Miroslav Penka, Jakub Radocha, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Juan José Lahuerta, Ludek Pour, Lucie Říhová, Roman Hájek
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Cristina Encinas, José-Ángel Hernandez-Rivas, Albert Ortiol, Laura Rosiñol, María-Jesús Blanchard, José-María Bellón, Miriam Santero, Javier de la Rubia, Ana López de la Guía, Ana Jímenez-Ubieto, Isidro Jarque, Belén Iñigo, Victoria Dourdil, Felipe De Arriba, Clara Cuéllar Pérez-Ávila, Yolanda Gonzalez, Miguel-Teodoro Hernández, Joan Bargay, Miquel Granell, Paula Rodríguez-Otero, Maialen Silvent, Carmen Cabrera, Rafael Rios, Adrian Alegre, Mercedes Gironella, Marta-Sonia Gonzalez, Anna Sureda, Maria Antonia Sampol, Enrique M Ocio, Isabel Krsnik, Antonio García, Aránzazu García-Mateo, Joan-Alfons Soler, Jesús Martín-Sánchez, José-María Arguiñano, Maria-Victoria Mateos-Manteca, Joan Bladé, Jesús San F Miguel, Juan-José Lahuerta, Joaquin Martinez Lopez, null null
A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma. Blood cancer journal 12 (4) (2022)
Mattia D'Agostino, David A Cairns, Juan-José Lahuerta, Ruth Wester, Uta Bertsch, Anders Waage, Elena Zamagni, Maria-Victoria Mateos-Manteca, Daniele Dall'Olio, Niels W C J van de Donk, Graham H Jackson, Serena Rocchi, Hans J Salwender, Joan Bladé Creixenti, Bronno van der Holt, Gastone C Castellani, Francesca Bonello, Andrea Capra, Elias Karl Mai, Jan Dürig, Francesca Gay, Sonja Zweegman, Michele Cavo, Martin F Kaiser, Hartmut Goldschmidt, Jesús María Hernández-Rivas, Alessandra Larocca, Curly T C M Morris, Jesús San F Miguel, Mario Boccadoro, Pieter Sonneveld
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)
Cirino Botta, Catarina Da Silva Maia, Juan-José Garcés, Rosalinda Termini, Cristina Perez, Irene Manrique, Leire Burgos, Aintzane Zabaleta, Diego Alignani, Sarai Sarvide, Juana Merino, Noemi Puig, Maria-Teresa Cedena, Marco Rossi, Pierfrancesco Tassone, Massimo Gentile, Pierpaolo Correale, Ivan M Borrello, Evangelos Terpos, Tomas Jelinek, Artur Paiva, Aldo M Roccaro, Hartmut Goldschmidt, Herve Avet-Loiseau, Laura Rosinol, Maria-Victoria Mateos-Manteca, Joaquin Martinez-Lopez, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Juan José Lahuerta
FlowCT for the analysis of large immunophenotypic datasets and biomarker discovery in cancer immunology. Blood advances (2021)
Jesús San F Miguel, Hervé Avet-Loiseau, Juan José Lahuerta, Shaji K Kumar, Meletios A A Dimopoulos, Thierry Facon, Maria-Victoria Mateos-Manteca, Cyrille Touzeau, Andrzej J Jakubowiak, Saad Z Usmani, Gordon Cook, Michele Cavo, Hang Quach, Jon Ukropec, Priya Ramaswami, Huiling Pei, Mia Qi, Steven Sun, Jianping Wang, Maria Krevvata, Nikki DeAngelis, Christoph Heuck, Rian Van Rampelbergh, Anupa Kudva, Rachel Kobos, Ming Qi, Nizar J Bahlis
Sustained Minimal Residual Disease Negativity With Daratumumab in Newly Diagnosed Multiple Myeloma: MAIA and ALCYONE. Blood (2021)
Noemí Puig, Juan A Flores-Montero, Leire Burgos, María-Teresa Cedena, Lourdes Cordón, José-Juan Pérez, Luzalba Sanoja-Flores, Irene Manrique, Paula Rodríguez-Otero, Laura Rosiñol, Joaquin Martinez Lopez, Maria-Victoria Mateos-Manteca, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Alberto Orfao, Juan José Lahuerta
Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma. Cancers 13 (19) (2021)
Luis-Esteban Tamariz-Amador, Anna Martina Battaglia, Catarina Maia, Anastasiia Zherniakova, Camilla Guerrero, Aintzane Zabaleta, Leire Burgos, Cirino Botta, Maria-Antonia Fortuño, Carlos Grande, Andrea Manubens, Jose-Maria Arguiñano, Clara Gomez, Ernesto Perez-Persona, Iñigo Olazabal, Itziar Oiartzabal, Carlos Panizo, Felipe Prosper, Jesús San F Miguel, Paula Rodriguez-Otero, Esperanza Martin-Sanchez, Juan José Lahuerta, null null
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies. Blood cancer journal 11 (12) (2021)
Luis Vitores Valcárcel, Ane Amundarain, Marta Kulis, Stella Charalampopoulou, Ari M Melnick, Jesús San F Miguel, José Ignacio Martin-Subero, Francisco J Planes, Xabier Agirre, Felipe Prosper
Gene expression derived from alternative promoters improves prognostic stratification in multiple myeloma. Leukemia 35 (10) (2021)
Herve Avet-Loiseau, Jesús San F Miguel, Tineke Casneuf, Shinsuke Iida, Sagar Lonial, Saad Z Usmani, Andrew Spencer, Philippe Moreau, Torben Plesner, Katja Weisel, Jon Ukropec, Christopher Chiu, Sonali Trivedi, Himal Amin, Maria Krevvata, Priya Ramaswami, Xiang Qin, Mia Qi, Steven Sun, Ming Qi, Rachel Kobos, Nizar J Bahlis
Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTOR. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (10) (2021)
Torben Plesner, Meletios- Athanasios Dimopoulos, Albert Oriol, Jesús San F Miguel, Nizar J Bahlis, Neil Rabin, Kenshi Suzuki, Sung-Soo Yoon, Dina Ben-Yehuda, Curly T C M Morris, Hartmut Goldschmidt, Sebastian Grosicki, Xiang Qin, John Fastenau, Wendy Garvin, Robin Carson, Thomas Renaud, Katharine S Gries
Health-related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial. British journal of haematology 194 (1) (2021)
Daniel Alameda, Ibai Goicoechea, Marco Vicari, Elena Arriazu, Alice Nevone, Sara Rodriguez, Marta Lasa, Noemi Puig, Maria Teresa Cedena, Diego Alignani, Sonia Garate, David Lara-Astiaso, Amaia Vilas-Zornoza, Sarai Sarvide, Enrique María Ocio, Ramon Lecumberri, Alfonso Garcia de Coca, Jorge Labrador, Maria-Esther Gonzalez, Luis Palomera, Mercedes Gironella, Valentín Cabañas, Maria Casanova, Albert Ortiol, Isabel Krsnik, Albert Perez-Montaña, Javier de la Rubia, José Enrique de la Puerta, Felipe de Arriba, Vito Michele Fazio, Joaquin Martinez Lopez, Juan-José Lahuerta, Maria-Victoria Mateos-Manteca, Maria-Dolores Odero, Felipe Prosper, Assaf Weiner, Ido Amit, Mario Nuvolone, Jesús San F Miguel, Juan José Lahuerta
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development. Blood 138 (17) (2021)
Phillipe Moreau, Razi Ghori, Mohammed Farooqui, Patricia Marinello, Jesús San F Miguel
Pembrolizumab combined with carfilzomib and low-dose dexamethasone for relapsed or refractory multiple myeloma: Cohort 2 of the phase I KEYNOTE-023 study. British journal of haematology 194 (1) (2021)
Giovanni Palladini, Juan José Lahuerta, Ashutosh Wechalekar, Margherita Massa, Paolo Milani, Marta Lasa, Sriram Ravichandran, Isabel Krsnik, Marco Basset, Leire Burgos, Mario Nuvolone, Ramón Lecumberri, Andrea Foli, Noemi Puig, Melania Antonietta Sesta, Margherita Bozzola, Pasquale Cascino, Alice Nevone, Jessica Ripepi, Pierpaolo Berti, Simona Casarini, Ombretta Annibali, Alberto Orfao, Jesús San F Miguel, Giampaolo Merlini
Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis. Blood cancer journal 11 (2) (2021)
Carlos Fernández de Larrea, Robert Kyle, Laura Rosinol, Juan José Lahuerta, Monika Engelhardt, Saad Z Usmani, Jo Caers, Wilson Gonsalves, Schjesvold Fredrik, Giampaolo Merlini, Suzanne Lentzch, Enrique Ocio, Laurent Garderet, Philippe Moreau, Pieter Sonneveld, Ashraf Badros, Gösta Gahrton, Hartmut Goldschmidt, Sascha A Tuchman, Hermann Einsele, Brian Durie, Baldeep Wirk, Pellegrino Musto, Patrick Hayden, Martin F Kaiser, Jesús San F Miguel, Joan Bladé, Sundararajan Vincent Rajkumar, Maria-Victoria Mateos-Manteca
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage. Blood cancer journal 11 (12) (2021)
Noemi Puig, Miguel-Teodoro T Hernandez Garcia, Laura Rosiñol, Esther González, Felipe de Arriba, Albert Ortiol, Verónica González-Calle, Fernando Escalante, Javier de la Rubia, Mercedes Gironella, Rafael Ríos, Ricarda García-Sánchez, José M Arguiñano, Adrián Alegre, Jesús Martín-Sánchez, Norma C Gutiérrez, María-José Calasanz, María L Martín, María Del Carmen Couto, María Casanova, Mario Arnao, Ernesto Pérez-Persona, Sebastián Garzón, Marta S González, Guillermo Martín-Sánchez, Enrique M Ocio, Morton Coleman, Cristina Encinas, Ana M Vale, Ana I Teruel, María Cortés-Rodríguez, Juan José Lahuerta, M Teresa Cedena, Jesús San F Miguel, Juan-José Lahuerta, Joan Bladé, Ruben Niesvizky, Maria-Victoria Mateos-Manteca
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial. Blood cancer journal 11 (5) (2021)
Arantxa Carrasco-Leon, Teresa Ezponda, Cem Meydan, Luis Vitores Valcárcel, Raquel Ordoñez, Marta Kulis, Leire Garate, Estíbaliz Miranda, Victor Segura, Elisabeth Guruceaga, Amaia Vilas-Zornoza, Diego Alignani, Marién Pascual, Ane Amundarain, Laura Castro-Labrador, Patxi San Martín-Uriz, Halima El-Omri, Ruba Y Taha, María-José Calasanz, Francisco J Planes, Juan José Lahuerta, Christopher E Mason, Jesús San F Miguel, José Ignacio Martin-Subero, Ari M Melnick, Felipe Prosper, Xabier Agirre
Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma. Leukemia 35 (5) (2021)
Ana Jiménez-Ubieto, Juan José Lahuerta, Noemi Puig, María-Teresa Cedena, Joaquin Martinez Lopez, Albert Ortiol, María-Jesús Blanchard, Rafael Ríos, Jesús Martin, Rafael Martínez, Anna Sureda, Miguel-Teodoro T Hernandez Garcia, Javier de la Rubia, Isabel Krsnik, Valentín Cabañas, Luis Palomera, José María Sánchez-Pina, Joan Bargay, Maria-Victoria Mateos-Manteca, Laura Rosinol, Joan Blade, Jesús San F Miguel, Juan-José Lahuerta, null null
Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change? Blood 138 (19) (2021)
Michele Cavo, Jesús San F Miguel, Saad Z Usmani, Katja C Weisel, Meletios A A Dimopoulos, Hervé Avet-Loiseau, Juan José Lahuerta, Nizar J Bahlis, Torben Plesner, Vania Tietsche de Moraes Hungria, Philippe Moreau, Maria-Victoria Mateos-Manteca, Aurore Perrot, Shinsuke Iida, Thierry Facon, Shaji K Kumar, Niels W C J van de Donk, Pieter Sonneveld, Andrew Spencer, Maria Krevvata, Christoph Heuck, Jianping Wang, Jon Ukropec, Rachel Kobos, Steven Sun, Mia Qi, Nikhil C Munshi
Prognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, MAIA. Blood (2021)
Maria-Victoria Mateos-Manteca, Shaji K Kumar, Meletios- Athanasios Dimopoulos, Verónica González-Calle, Efstathios Kastritis, Roman Hajek, Carlos Fernández De Larrea, Gareth J Morgan, Giampaolo Merlini, Hartmut Goldschmidt, Catarina Geraldes, Alessandro Gozzetti, Charalampia Kyriakou, Laurent Garderet, Markus Hansson, Elena Zamagni, Dorotea Fantl, Xavier Leleu, Byung-Su Kim, Graça Esteves, Heinz Ludwig, Saad Z Usmani, Chang-Ki Min, Ming Qi, Jon Ukropec, Brendan M Weiss, Sundararajan Vincent Rajkumar, Brian G M Durie, Jesús San F Miguel
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM). Blood cancer journal 10 (10) (2020)
Joaquin Martinez Lopez, Maria-Victoria Mateos-Manteca, Cristina Encinas, Anna Sureda, José Ángel Hernández-Rivas, Ana Lopez de la Guía, Diego Conde, Isabel Krsnik, Elena Prieto, Rosalía Riaza Grau, Mercedes Gironella, María Jesús Blanchard, Nerea Caminos, Carlos Fernández de Larrea, María Alicia Senin, Fernando Escalante, José Enrique de la Puerta, Eugenio Giménez, Pilar Martínez-Barranco, Juan José Mateos, Luis Felipe Casado, Joan Bladé, Juan-José Lahuerta, Javier de la Cruz, Jesús San F Miguel
Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality. Blood cancer journal 10 (10) (2020)
Ravi Vij, Rajneesh Nath, Daniel E H Afar, María-Victoria Mateos, Jesús G Berdeja, Marc S Raab, Andreas Guenther, Joaquín Martínez-López, Andrzej J Jakubowiak, Xavier Leleu, Katja Weisel, Shekman Wong, Scott Gulbranson, James P Sheridan, Anita Reddy, Bruno Paiva, Anil Singhal, Jesús San F Miguel, Philippe Moreau
First-in-Human Phase I Study of ABBV-838, an Antibody-Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (10) (2020)
Alejandro Medina Herrera, Noemi Puig, Juan A Flores-Montero, Cristina Jimenez, María Eugenia Sarasquete, María Garcia-Alvarez, Isabel Prieto-Conde, Carmen Chillon, Miguel Alcoceba, Norma C Gutierrez, Albert Oriol, Laura Rosinol, Joan Bladè, Mercedes Gironella, Miguel T Hernandez, Veronica Gonzalez-Calle, Maria-Teresa Cedena, Juan José Lahuerta, Jesús San F Miguel, Juan-José Lahuerta, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Alberto Orfao, Marcos Gonzalez, Miriam Santero
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma. Blood cancer journal 10 (10) (2020)
Enrique María Ocio, Cristina Motlló, Paula Rodríguez-Otero, Joaquin Martinez-Lopez, Mª José Cejalvo, Jesús Martín-Sánchez, Joan Bladé, Mª Dolores García-Malo, Mª Victoria Dourdil, Aránzazu García-Mateo, Felipe de Arriba, Ramón García-Sanz, Javier de la Rubia, Albert Oriol, Juan-José Lahuerta, Jesús San F Miguel, Maria-Victoria Mateos-Manteca
Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1-acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group. British journal of haematology 192 (3) (2020)
Leire Burgos, Noemi Puig, Maria-Teresa Cedena, María-Victoria Mateos, Juan José Lahuerta, Bruno Paiva, Jesús San F Miguel
Measurable residual disease in multiple myeloma: ready for clinical practice? Journal of hematology & oncology 13 (1) (2020)
Jonathan L Kaufman, Meletios- Athanasios Dimopoulos, Darrell White, Lotfi Benboubker, Gordon Cook, Merav Leiba, James Morton, P Joy Ho, Kihyun Kim, Naoki Takezako, Philippe Moreau, Heather J Sutherland, Hila Magen, Shinsuke Iida, Jin Seok Kim, H Miles Prince, Tara Cochrane, Albert Oriol, Nizar J Bahlis, Ajai Chari, Lisa O'Rourke, Sonali Trivedi, Tineke Casneuf, Maria Krevvata, Jon Ukropec, Rachel Kobos, Hervé Avet-Loiseau, Saad Z Usmani, Jesús San F Miguel
Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX. Blood cancer journal 10 (11) (2020)
Saad Z Usmani, Hareth Nahi, Maria-Victoria Mateos, Niels W C J van de Donk, Ajai Chari, Jonathan L Kaufman, Philippe Moreau, Albert Ortiol, Torben Plesner, Lofti Benboubker, Peter Hellemans, Tara Masterson, Pamela L Clemens, Man Luo, Kevin Liu, Jesús San F Miguel
Subcutaneous delivery of daratumumab in relapsed or refractory multiple myeloma. Blood 134 (8) (2019)
Maria-Victoria Mateos-Manteca, Robert Z Orlowski, Enrique María Ocio, Paula Rodríguez-Otero, Donna Reece, Phillipe Moreau, Nikhil Munshi, David E Avigan, David S Siegel, Razi Ghori, Mohammed Z H Farooqui, Patricia Marinello, Jesús San F Miguel
Pembrolizumab combined with lenalidomide and low-dose dexamethasone for relapsed or refractory multiple myeloma: phase I KEYNOTE-023 study. British journal of haematology 186 (5) (2019)
Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Hartmut Goldschmidt, Pieter Sonneveld, Meletios- Athanasios Dimopoulos, Bart Heeg, Mahmoud Hashim, William Deraedt, Peter Hu, Annette Lam, Jianming He
The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparison. Leukemia & lymphoma 61 (3) (2019)
Juan-José Lahuerta, Ana Jiménez-Ubieto, Bruno Paiva, Joaquin Martinez Lopez, José González-Medina, Lucía López-Anglada, María-Teresa Cedena, Noemi Puig, Albert Ortiol, María-Jesús Blanchard, Rafael Rios-Tamayo, Jesús Martin, Rafael Martínez, Anna Sureda, Miguel Teodoro Hernández, Javier de la Rubia, Isabel Krsnik, Valentín Cabañas, Luis Palomera, Joan Bargay, María-Victoria Mateos, Laura Rosiñol, Jesús San F Miguel, Joan Blade
Role of urine immunofixation in the complete response assessment of MM patients other than light-chain-only disease. Blood 133 (25) (2019)
Jesús San F Miguel, Vania T M Hungria, Sung-Soo Yoon, Meral Beksac, Meletios- Athanasios Dimopoulos, Ashraf Elghandour, Wieslaw W Jedrzejczak, Andreas Guenther, Thanyaphong Na Nakorn, Noppadol Siritanaratkul, Robert L Schlossman, Jian Hou, Phillipe Moreau, Sagar Lonial, Jae-Hoon Lee, Hermann Einsele, Hans Salwender, Monika Sopala, Suman Redhu, Sofia Paul, Claudia Corrado, Paul G Richardson
Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trial. British journal of haematology 179 (1) (2017)
Meletios- Athanasios Dimopoulos, Sagar Lonial, Darrell White, Phillipe Moreau, Antonio Palumbo, Jesús San F Miguel, Ofer Shpilberg, Kenneth Anderson, Sebastian Grosicki, Ivan Spicka, Adam Walter-Croneck, Hila Magen, Maria-Victoria Mateos, Andrew Belch, Donna Reece, Meral Beksac, Eric Bleickardt, Valerie Poulart, Jennifer Sheng, Oumar Sy, Jessica Katz, Anil Singhal, Paul Richardson
Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT-2 follow-up and post-hoc analyses on progression-free survival and tumour growth. British journal of haematology 178 (6) (2017)

Jesús San F Miguel.css-eqlu8i{font-size:small;padding-left:4px;} (Jesús San Miguel, Jesús F San-Miguel, J F San Miguel, Jesus F San-Miguel, Jesús San Miguel, Jesus San Miguel, Jesús San-Miguel, Jesús F San Miguel, Jesus F San Miguel, Jesus San-Miguel, Jesus F F San-Miguel)

Publication Activity (10 Years)

Top Topics

Top Venues

Jesús San F Miguel (Jesús San Miguel, Jesús F San-Miguel, J F San Miguel, Jesus F San-Miguel, Jesús San Miguel, Jesus San Miguel, Jesús San-Miguel, Jesús F San Miguel, Jesus F San Miguel, Jesus San-Miguel, Jesus F F San-Miguel)